The United States Food and Drug Administration says the shortage of Eli Lilly’s Zepbound and Mounjaro drugs has been resolved and that specialty pharmacies and online companies need to stop ...

Both Lilly and Novo Nordisk are experiencing unprecedented growth thanks to their weight loss medications. However, Lilly also treats cancer, plaque psoriasis, Alzheimer's disease, eczema ...

In the time since, though, some analysts have said the reaction is overblown, particularly for weight-loss drugmakers like Wegovy, and Ozempic maker Novo Nordisk and Zepbound maker Eli Lilly.

Eli Lilly and Company (NYSE: LLY) today announced the U.S. Food and Drug Administration (FDA) approved Zepbound® (tirzepatide) as the first and only prescription medicine for adults with moderate ...

US Senators are concerned that Pfizer and Eli Lilly's recent forays into direct-to-consumer distribution of medicines via telehealth platforms could violate federal anti-kickback laws. The four ...

Eli Lilly (NYSE: LLY) and Novo Nordisk (NYSE: NVO) have attracted a lot of attention over the past two years thanks to their advances in the weight loss therapy market. Musk revealed using Novo ...

After hours: 7:58:21 p.m. EST ...

Partly cloudy. Winds southwesterly 25 to 40 km/h becoming light in the late evening. Sun protection recommended from 9:00 am to 5:20 pm, UV Index predicted to reach 10 [Very High] Mostly sunny morning ...

After hours: 27 December at 7:58:21 pm GMT-5 ...